Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Cluster of Differentiation 20 Expression and Rituximab Use Do Not Improve Outcome of Classical Hodgkin Lymphoma Patients

Khadega A Abuelgasim, Raed Al Shammari, Saeed Alshieban, Bader Alahmari, MD, Mohsen Alzahrani, Ayman Alhejazi, MD, Ahmed Alaskar, Moussab Damlaj

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-135917

Published: 2020

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

Journal Articles

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Bader Alahmari, MD, Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Julie Ritchey, Bing Wang, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3344.

https://doi.org/10.1182/blood.V128.22.3344.3344

Published: 2016

Journal Articles

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Jaebok Choi, PhD, Matthew L Cooper, PhD, Kiran R. Vij, MD, Bing Wang, Julie Ritchey, Bader Alahmari, MD, Matthew Holt, John F DiPersio, MD PhD

Blood (2016) 128 (22): 3353.

https://doi.org/10.1182/blood.V128.22.3353.3353

Published: 2016

Journal Articles

Targeting VLA-4 to Reduce GvHD

Jaebok Choi, PhD, Matthew L Cooper, PhD, Bader Alahmari, MD, Julie Ritchey, John F. DiPersio, MD PhD

Blood (2014) 124 (21): 3829.

https://doi.org/10.1182/blood.V124.21.3829.3829

Published: 2014

NARROW

Cluster of Differentiation 20 Expression and Rituximab Use Do Not Improve Outcome of Classical Hodgkin Lymphoma Patients

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Targeting VLA-4 to Reduce GvHD

Email alerts

ASH Publications

American Society of Hematology

Cluster of Differentiation 20 Expression and Rituximab Use Do Not Improve Outcome of Classical Hodgkin Lymphoma Patients

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Selective Inhibition of α4β1 Integrin (VLA-4) Mitigates GvHD

Pharmacologic Co-Blockade of IFNγR and IL6R Pathways to Prevent and Treat GvHD

Targeting VLA-4 to Reduce GvHD

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only